title: Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
abstract: Reports of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in the pediatric community have exploded during the past decade. These infections typically result in mild skin and soft tissue infections that can be managed simply with oral antimicrobials. Recently, there have been reports of invasive CA-MRSA infecting children without risk factors, with isolated cases of life-threatening disease. We report 2 atypical cases of invasive CA-MRSA infecting previously healthy children.
authors.affiliation: Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan and Wayne State University School of Medicine, Detroit, MI 48201, USA. cstankov@dmc.org
authors.forename: Curt
authors.initials: C
authors.lastname: Stankovic
authors.forename: Prashant V
authors.initials: PV
authors.lastname: Mahajan
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007223:Infant; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D012445:Sacrococcygeal Region / Q000382:microbiology; D012535:Scalp / Q000382:microbiology; D012782:Shoulder / Q000382:microbiology; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D002981:Clindamycin; D014640:Vancomycin